Beijing Airdoc Technology Co., Ltd. is a leading health technology company focused on innovative AI-driven diagnostic solutions in the field of ophthalmology and general medical screening. The company's primary function is to develop and provide advanced medical imaging applications that utilize artificial intelligence to enhance the diagnosis and management of various health conditions, particularly those detectable through ocular examinations. Airdoc's notable products include AI-based software that can analyze retinal images to detect diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration.

The company significantly impacts the healthcare technology sector, emphasizing precision medicine and preventive care. By integrating cutting-edge AI technologies into medical diagnostics, Beijing Airdoc aims to improve early detection rates and health outcomes while reducing the workload on healthcare professionals. As the demand for enhanced medical diagnostic tools increases globally, Airdoc's innovative solutions hold a critical role in modernizing healthcare delivery systems. Their technology not only aids in personal healthcare management but also supports public health initiatives by facilitating accessible and efficient health screenings in both urban and rural settings.